Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1; no core study content or user-facing details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.1 appears on the page, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No visible content or layout changes to the study page were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedUI and metadata updates include enabling Show glossary, capitalization adjustments to QC-related labels (Last Update Submitted that Met QC Criteria and No FEAR Act data), and a site revision upgrade to v3.4.0.SummaryDifference0.2%

- Check54 days agoChange DetectedLast Update Posted timestamp is now displayed, and the Last Update Posted (Estimated) label has been removed.SummaryDifference0.0%

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.